Crossmark

Evaluation and comparison of efficacy and safety of tirzepatide, liraglutide and SGLT2i in patients with type 2 diabetes mellitus: a network meta-analysis

Crossref DOI link: https://doi.org/10.1186/s12902-024-01805-z

Published Online: 2024-12-24

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Teng, Yunjie

Fan, Xue

Yu, Rui

Yang, Xiaoping
License Information

Text and Data Mining valid from 2024-12-24

Version of Record valid from 2024-12-24
More Information

Article History

Received: 27 July 2024

Accepted: 9 December 2024

First Online: 24 December 2024

Declarations

:

: This is a systematic review and meta-analysis, ethics approval and consent to participate are not applicable.

: Not applicable. This study does not involve human participants.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below